GSTT - Provision of Aseptic Managed Service (Великобритания (Англия, Шотландия, Уэльс) - Тендер #45946582) | ||
| ||
| Для перевода текста тендера на нужный язык воспользуйтесь приложением: | ||
Страна: Великобритания (Англия, Шотландия, Уэльс) (другие тендеры и закупки Великобритания (Англия, Шотландия, Уэльс)) Организатор тендера: Guy"s and St Thomas" NHS Foundation Trust Номер конкурса: 45946582 Дата публикации: 08-09-2023 Источник тендера: Государственные закупки Уэльса (часть Соединённого Королевства Великобритании и Северной Ирландии) |
||
| Title: | GSTT - Provision of Aseptic Managed Service |
| OCID: | ocds-h6vhtk-03faf2 |
| Published by: | Guy"s and St Thomas" NHS Foundation Trust |
| Authority ID: | AA30334 |
| Publication Date: | 08/09/2023 |
| Deadline Date: | |
| Deadline Time: | |
| Notice Type: | Prior Information Notice |
| Has Documents: | No |
| Has SPD: | No |
| Abstract: |
The proposed aseptic service will have the capability and capacity to deliver timely and reliable medicines for chemotherapy, Parenteral Nutrition, CIVAS antibiotics, clinical trials and also support growing demand for advanced gene therapies. Quality and patient safety considerations are key with drug compounding including aseptically prepared, hazardous chemotherapy drugs and investigational medicinal. Innovation driven by Research and Development is key to support GSTT’s ambitions in being at the forefront of aseptic services. The new service will meet both today’s and future needs of our patients, supplying tailored made drugs, to the right patient, at the right time, at the right quality, safely and also support GSTT’s track record of being a leader in implementing new innovative treatments.<br/><br/>Partners will work with GSTT to design an aseptic service which considers both onsite and offsite aseptic units to meet patient and clinical needs. The new model of delivery will include investment in new sterile aseptic units, state of the art robotic equipment, IT production management systems, drug compounds, support with staffing and training and other supporting services required to deliver quality medicines. A long-term partnership is envisaged of 10 to 15 years to establish the capacity to meet the growing demands for aseptic drugs for patients. Commercial aseptic sales opportunities will be explored to maximise the investment and deliver wider benefit to the NHS. |
This notice is for prior information only
Guy"s and St Thomas" NHS Foundation Trust
Great Maze Pond
London
SE1 9RT
UK
Contact person: Kemi Ore
Telephone: +44 207887188
E-mail: kemi.ore@gstt.nhs.uk
NUTS: UKI44
Internet address(es)
Main address: https://www.guysandstthomas.nhs.uk
Address of the buyer profile: https://www.guysandstthomas.nhs.uk
Additional information can be obtained from the abovementioned address
Electronic communication requires the use of tools and devices that are not generally available. Unrestricted and full direct access to these tools and devices is possible, free of charge, at:
https://health-family.force.com/s/Welcome
Body governed by public law
Health
GSTT - Provision of Aseptic Managed Service
Reference number: ST23-P076
II.1.2) Main CPV code85149000
II.1.3) Type of contractServices
II.1.4) Short descriptionThe Trust has a requirement for controlled environments for the preparation of high-risk injectable medicines into ready-to-administer (RtA) formats for patients. Aseptic facilities are also required for the manufacture of Advanced Therapy medicines including gene, cell and viral therapies, and a growing number of Investigational Medicinal Products used in clinical trials.
II.1.6) Information about lotsThis contract is divided into lots: No
33600000
33000000
33690000
33692000
33692100
33692210
33692200
33692510
33692500
33692300
II.2.3) Place of performanceNUTS code:
UKI
II.2.4) Description of the procurementThe proposed aseptic service will have the capability and capacity to deliver timely and reliable medicines for chemotherapy, Parenteral Nutrition, CIVAS antibiotics, clinical trials and also support growing demand for advanced gene therapies. Quality and patient safety considerations are key with drug compounding including aseptically prepared, hazardous chemotherapy drugs and investigational medicinal. Innovation driven by Research and Development is key to support GSTT’s ambitions in being at the forefront of aseptic services. The new service will meet both today’s and future needs of our patients, supplying tailored made drugs, to the right patient, at the right time, at the right quality, safely and also support GSTT’s track record of being a leader in implementing new innovative treatments.<br/><br/>Partners will work with GSTT to design an aseptic service which considers both onsite and offsite aseptic units to meet patient and clinical needs. The new model of delivery will include investment in new sterile aseptic units, state of the art robotic equipment, IT production management systems, drug compounds, support with staffing and training and other supporting services required to deliver quality medicines. A long-term partnership is envisaged of 10 to 15 years to establish the capacity to meet the growing demands for aseptic drugs for patients. Commercial aseptic sales opportunities will be explored to maximise the investment and deliver wider benefit to the NHS.
II.2.14) Additional informationGSTT Aseptic Services is one of two divisions of Pharmacy Technical Services, with the other division being the Pharmacy Specials Manufacturing Unit which is out of scope of this PIN. <br/>Pharmacy Technical Services is part of the Pharmacy and Medicines Optimisation Division which is also responsible for outpatient pharmacy services. The Pharmacy and Medicines Optimisation Division forms part of GSTTs Integrated and Specialised Medicine Clinical Group.
07/09/2023
The procurement is covered by the Government Procurement Agreement: No
Suppliers are asked to complete a Questionnaire available to download from the Tender Box to respond to this PIN Notice with a deadline for responses of 12th October 2023
07/09/2023
Information added to the notice since publication.
Additional information added to the notice since it"s publication.| No further information has been uploaded. |
| Main Contact: | kemi.ore@gstt.nhs.uk |
| Admin Contact: | N/a |
| Technical Contact: | N/a |
| Other Contact: | N/a |
| ID | Title | Parent Category |
|---|---|---|
| 33692300 | Enteral feeds | Medical solutions |
| 33692100 | Infusion solutions | Medical solutions |
| 33692500 | Injectable solutions | Medical solutions |
| 33692510 | Intravenous fluids | Medical solutions |
| 33000000 | Medical equipments, pharmaceuticals and personal care products | Materials and Products |
| 33692000 | Medical solutions | Various medicinal products |
| 33692210 | Parenteral feeding solutions | Medical solutions |
| 33692200 | Parenteral nutrition products | Medical solutions |
| 33600000 | Pharmaceutical products | Medical equipments, pharmaceuticals and personal care products |
| 85149000 | Pharmacy services | Miscellaneous health services |
| 33690000 | Various medicinal products | Pharmaceutical products |
| ID | Description |
|---|---|
| 100 | UK - All |
The buyer has restricted the alert for this notice to suppliers based in the following regions.
Alert Region Restrictions| There are no alert restrictions for this notice. |